CEL SCI CORP cotiza a 1.83 USD y tiene una capitalización bursátil de $32M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
CEL-SCI Corporation, a clinical-stage biotechnology company, engages in the research and development to treat cancer and other diseases by using the immune system in the United States. The company's lead immunotherapy is Multikine, which has completed Phase III clinical trials for the potential treatment of certain hea…
| Periodo | 2026-02 | 2025-01 | 2024-08 | 2024-05 |
|---|---|---|---|---|
| Real | — | $-2.70 | $-4.20 | $-8.40 |
| Estimado | — | $-3.30 | $-3.90 | $-4.20 |
| Sorpresa | — | +18.2% | -7.7% | -100.0% |
| Métrica | CVM | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | — | -38.6% | — |
| Net Margin | — | -33.6% | — |
| FCF Margin | — | -13.9% | — |
| ROE | -159.3% | -40.4% | -118.8% |
| ROA | -90.3% | -32.0% | -58.2% |
| Current Ratio | 2.26 | 2.84 | -0.58 |
| Debt / Equity | 0.36 | 0.28 | +0.08 |